Related Experiment Video
Updated: Feb 17, 2026
07:02
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
14.4K
Recent advances in spasmolytic polypeptide expressing metaplasia research
Rui-Rui Yang1,2, Ya-Ru Yan3, Yu-Feng Li4
1First Clinical School, Liaoning University of Chinese Medicine, Shenyang 110847, Liaoning Province, China.
World Journal of Gastrointestinal Oncology
|February 16, 2026
Summary
Spasmolytic polypeptide-expressing metaplasia is a key driver of gastric cancer. Understanding its mechanisms offers new avenues for early intervention and prevention strategies against this deadly disease.
Area of Science:
- Gastroenterology and Oncology
- Molecular Pathogenesis
Background:
- Gastric cancer is a major global health burden with poor outcomes.
- Limited progress in prevention and treatment stems from incomplete understanding of disease development.
- Spasmolytic polypeptide-expressing metaplasia (SPEM) is recognized as a critical precancerous lesion.
Purpose of the Study:
- To review recent advances in understanding the mechanistic roles of SPEM in gastric mucosal diseases.
- To elucidate the pathways involved in SPEM-driven gastric carcinogenesis.
- To provide insights for developing novel strategies for early gastric cancer intervention and prevention.
Main Methods:
- Comprehensive literature review of recent research on SPEM and gastric carcinogenesis.
- Analysis of mechanistic studies elucidating the role of SPEM in gastric mucosal diseases.
- Synthesis of findings to identify key pathways and therapeutic targets.
Main Results:
- SPEM plays a critical role in the progression of gastric mucosal abnormalities towards cancer.
- Specific molecular pathways driven by SPEM have been identified as key contributors to carcinogenesis.
- Understanding these pathways is crucial for targeting early stages of gastric disease.
Conclusions:
- SPEM is a significant factor in gastric carcinogenesis, acting through specific molecular mechanisms.
- Elucidation of SPEM's role provides a foundation for developing targeted early detection and prevention strategies.
- Further research into SPEM pathways may lead to improved outcomes for gastric cancer patients.
Related Concept Videos
01:29Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K